{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:07:05Z","timestamp":1787026025447,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T00:00:00Z","timestamp":1494028800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12640-017-9747-4","type":"journal-article","created":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T02:02:39Z","timestamp":1494036159000},"page":"362-367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["DT-diaphorase Protects Against Autophagy Induced by Aminochrome-Dependent Alpha-Synuclein Oligomers"],"prefix":"10.1007","volume":"32","author":[{"given":"Patricia S.","family":"Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Segura-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,6]]},"reference":[{"key":"9747_CR1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho W, Castillo P, Shinsky N, Verdugo J, Armanini M, Ryan A et al (2000) Mice lacking \u03b1-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25:239\u2013252","journal-title":"Neuron"},{"key":"9747_CR2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.nbd.2004.03.014","volume":"16","author":"C Arriagada","year":"2004","unstructured":"Arriagada C, Paris I, Sanchez de las Matas M, Martinez-Alvarado P, Cardenas S, Castaneda P, Graumann R, Perez-Pastene C, Olea-Azar C, Couve E (2004) On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation. Neurobiol Dis 16:468\u2013477","journal-title":"Neurobiol Dis"},{"key":"9747_CR3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainres.2012.04.014","volume":"1476","author":"A Bellucci","year":"2012","unstructured":"Bellucci A, Zaltieri M, Navarria L, Grigoletto J, Missale C, Spano P (2012) From \u03b1-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson\u2019s disease. Brain Res 1476:183\u2013202","journal-title":"Brain Res"},{"issue":"21","key":"9747_CR4","doi-asserted-by":"crossref","first-page":"15597","DOI":"10.1074\/jbc.M610893200","volume":"282","author":"M Bisaglia","year":"2007","unstructured":"Bisaglia M, Mammi S, Bubacco L (2007) Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein. J Biol Chem 282(21):15597\u201315605","journal-title":"J Biol Chem"},{"issue":"2","key":"9747_CR5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbrc.2010.03.044","volume":"394","author":"M Bisaglia","year":"2010","unstructured":"Bisaglia M, Tosatto L, Munari F, Tessari I, de Laureto PP, Mammi S, Bubacco L (2010) Dopamine quinones interact with alpha-synuclein to form unstructured adducts. Biochem Biophys Res Commun 394(2):424\u2013428","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"9747_CR6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0166-2236(97)01213-7","volume":"21","author":"DF Clayton","year":"1998","unstructured":"Clayton DF, George JM (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 21(6):249\u2013254","journal-title":"Trends Neurosci"},{"key":"9747_CR7","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","volume":"294","author":"K Conway","year":"2001","unstructured":"Conway K, Rochet J, Bieganski R, Lansbury P (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294:1346\u20131349","journal-title":"Science"},{"issue":"e","key":"9747_CR8","doi-asserted-by":"crossref","first-page":"9313","DOI":"10.1371\/journal.pone.0009313","volume":"5","author":"L Crews","year":"2010","unstructured":"Crews L, Spencer B, Desplats P, Patrick C, Paulino A, Rockenstein E, Hansen L, Adame A, Galasko D, Masliah E (2010) Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of \u03b1-synucleinopathy. PLoS One 5(e):9313","journal-title":"PLoS One"},{"key":"9747_CR9","doi-asserted-by":"publisher","unstructured":"Cuervo AM (2008) Autophagy and aging: keeping that old broom working. Trends Genet 24(12):604\u201312. doi:\n10.1016\/j.tig.2008.10.002","DOI":"10.1016\/j.tig.2008.10.002"},{"key":"9747_CR10","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"A Cuervo","year":"2004","unstructured":"Cuervo A, Stefanis L, Fredenburg R, Lansbury P, Sulzer D (2004) Impaired degradation of mutant alpha-synuclein by chaperonemediated autophagy. Science 305:1292\u20131295","journal-title":"Science"},{"key":"9747_CR11","doi-asserted-by":"publisher","unstructured":"Domert J, Sackmann C, Severinsson E, Agholme L, Bergstr\u00f6m J, Ingelsson M, Hallbeck M (2016) Aggregated alpha-synuclein transfer efficiently between cultured human neuron-like cells and localize to lysosomes. PLoS One 11(12):e0168700. doi:\n10.1371\/journal.pone.0168700","DOI":"10.1371\/journal.pone.0168700"},{"key":"9747_CR12","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1523\/JNEUROSCI.1560-11.2011","volume":"31","author":"D Ebrahimi-Fakhari","year":"2011","unstructured":"Ebrahimi-Fakhari D, Cantuti-Castelvetri I, Fan Z, Rockenstein E, Masliah E, Hyman B, McLean P, Unni V (2011) Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of \u03b1-synuclein. J Neurosci 31:14508\u201314520","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"9747_CR13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(98)01418-5","volume":"440","author":"OM El-Agnaf","year":"1998","unstructured":"El-Agnaf OM, Jakes R, Curran MD, Middleton D, Ingenito R, Bianchi E, Pessi A, Neill D, Wallace A (1998) Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett 440(1\u20132):71\u201375","journal-title":"FEBS Lett"},{"key":"9747_CR14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/1735-1995.181989","volume":"21","author":"FN Emamzadeh","year":"2016","unstructured":"Emamzadeh FN (2016) Alpha-synuclein structure, functions, and interactions. J Res Med Sci 21:29","journal-title":"J Res Med Sci"},{"key":"9747_CR15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neurobiolaging.2008.07.008","volume":"31","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Stefanis L, Vekrellis K (2010) Cell-produced \u03b1-synuclein oligomers are targeted to, and impair, the 26S proteasome. Neurobiol Aging 31:953\u2013968","journal-title":"Neurobiol Aging"},{"key":"9747_CR16","unstructured":"George JM (2002) The synucleins. \u200bGenome Biol 3(1):REVIEWS3002"},{"issue":"4","key":"9747_CR17","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M008919200","volume":"276","author":"BI Giasson","year":"2001","unstructured":"Giasson BI, Murray IV, Trojanowski JQ, Lee VM (2001) A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem 276(4):2380\u20132386","journal-title":"J Biol Chem"},{"key":"9747_CR18","doi-asserted-by":"crossref","unstructured":"Gruden MA, Davydova TV, Narkevich VB, Fomina VG, Wang C, Kudrin VS, Morozova-Roche LA, Sewell RD (2014) Intranasal administration of alpha-synuclein aggregates: a Parkinson\u2019s disease model with behavioural and neurochemical correlates. Behav Brain Res 263:158\u2013168","DOI":"10.1016\/j.bbr.2014.01.017"},{"key":"9747_CR19","doi-asserted-by":"publisher","DOI":"10.1021\/ acschemneuro.7b00034","author":"A Herrera","year":"2017","unstructured":"Herrera A, Mu\u00f1oz P, Steinbusch HW, Segura-Aguilar J (2017) Are dopamine oxidation metabolites involved in the loss of dopaminergic neurons in the nigrostriatal system in Parkinson\u2019s disease? ACS Chem Neurosci. doi:\n10.1021\/ acschemneuro.7b00034","journal-title":"ACS Chem Neurosci"},{"key":"9747_CR20","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4161\/auto.27720","volume":"10","author":"S Huenchuguala","year":"2014","unstructured":"Huenchuguala S, Mu\u00f1oz P, Zavala P, Villa M, Cuevas C, Ahumada U, Graumann R, Nore B, Couve E, Mannervik B et al (2014) Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction. Autophagy 10:618\u2013630","journal-title":"Autophagy"},{"key":"9747_CR21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fnins.2016.00408","volume":"10","author":"M Ingelsson","year":"2016","unstructured":"Ingelsson M (2016) Alpha-synuclein oligomers-neurotoxic molecules in Parkinson\u2019s disease and other Lewy body disorders. Front Neurosci 10:408","journal-title":"Front Neurosci"},{"key":"9747_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ (2016) Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12:1\u2013222","journal-title":"Autophagy"},{"key":"9747_CR23","doi-asserted-by":"crossref","unstructured":"Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PT Jr (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291","DOI":"10.1038\/418291a"},{"key":"9747_CR24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.1079293","volume":"299","author":"C Liu","year":"2003","unstructured":"Liu C, Corboy M, DeMartino G, Thomas P (2003) Endoproteolytic activity of the proteasome. Science 299:408\u2013411","journal-title":"Science"},{"key":"9747_CR25","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/tx100182a","volume":"23","author":"J Lozano","year":"2010","unstructured":"Lozano J, Mu\u00d1oz P, Nore B, Ledoux S, Segura-Aguilar J (2010) Stable expression of short interfering RNA for DTdiaphorase induces neurotoxicity. Chem Res Toxicol 23:1492\u20131496","journal-title":"Chem Res Toxicol"},{"key":"9747_CR26","doi-asserted-by":"crossref","first-page":"13621","DOI":"10.1074\/jbc.M109.074617","volume":"285","author":"S Mak","year":"2010","unstructured":"Mak S, McCormack A, Manning-Bog A, Cuervo A, Di Monte D (2010) Lysosomal degradation of \u03b1-synuclein in vivo. J Biol Chem 285:13621\u201313629","journal-title":"J Biol Chem"},{"key":"9747_CR27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2005.05.010","volume":"46","author":"E Masliah","year":"2005","unstructured":"Masliah E, Rockenstein E, Adame A, Alford M, Crews L, Hashimoto M, Seubert P, Lee M, Goldstein J, Chilcote T, Games D, Schenk D (2005) Effects of alpha-synuclein immunization in a mouse model of Parkinson\u2019s disease. Neuron 46:857\u2013868","journal-title":"Neuron"},{"key":"9747_CR28","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.bbadis.2012.03.010","volume":"1822","author":"P Mu\u00f1oz","year":"2012","unstructured":"Mu\u00f1oz P, Paris I, Sanders LH, Greenamyre JT, Segura-Aguilar J (2012) Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity. Biochim Biophys Acta 1822:1125\u20131136","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"9747_CR29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/toxsci\/kfv016","volume":"145","author":"P Mu\u00f1oz","year":"2015","unstructured":"Mu\u00f1oz P, Cardenas S, Huenchuguala S, Brice\u00f1o A, Couve E, Paris I, Segura-Aguilar J (2015) DT-diaphorase prevents aminochrome-induced alpha-synuclein oligomer formation and neurotoxicity. Toxicol Sci 145(1):37\u201347","journal-title":"Toxicol Sci"},{"key":"9747_CR30","doi-asserted-by":"crossref","first-page":"12305","DOI":"10.1523\/JNEUROSCI.3088-08.2008","volume":"28","author":"K Nakamura","year":"2008","unstructured":"Nakamura K, Nemani V, Wallender E, Kaehlcke K, Ott M, Edwards R (2008) Optical reporters for the conformation of \u03b1-synuclein reveal a specific interaction with mitochondria. J Neurosci 28:12305\u201312317","journal-title":"J Neurosci"},{"key":"9747_CR31","doi-asserted-by":"crossref","first-page":"21212","DOI":"10.1074\/jbc.M412621200","volume":"280","author":"E Norris","year":"2005","unstructured":"Norris E, Giasson B, Hodara R, Xu S, Trojanowski J, Ischiropoulos H, Lee V (2005) Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations. J Biol Chem 280:21212\u201321219","journal-title":"J Biol Chem"},{"issue":"1","key":"9747_CR32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1515\/hsz-2016-0201","volume":"398","author":"D Ottolini","year":"2017","unstructured":"Ottolini D, Cal\u00ed T, Szab\u00f2 I, Brini M (2017) Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications. Biol Chem 398(1):77\u2013100","journal-title":"Biol Chem"},{"key":"9747_CR33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF03033505","volume":"13","author":"I Paris","year":"2008","unstructured":"Paris I, Lozano J, Cardenas S, Perez-Pastene C, Saud K, Fuentes P, Caviedes P, Dagnino-Subiabre A, RaismanVozari R, Shimahara T (2008) The catecholaminergic RCSN-3 cell line: a model to study dopamine metabolism. Neurotox Res 13:221\u2013230","journal-title":"Neurotox Res"},{"key":"9747_CR34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12640-009-9148-4","volume":"18","author":"I Paris","year":"2010","unstructured":"Paris I, Perez-Pastene C, Cardenas S, Iturriaga-Vasquez P, Mu\u00f1oz P, Couve E, Caviedes P, Segura-Aguilar J (2010) Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line. Neurotox Res 18:82\u201392","journal-title":"Neurotox Res"},{"key":"9747_CR35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/toxsci\/kfr060","volume":"121","author":"I Paris","year":"2011","unstructured":"Paris I, Mu\u00f1oz P, Huenchuguala S, Couve E, Sanders LH, Greenamyre JT, Caviedes P, Segura-Aguilar J (2011) Autophagy protects against aminochrome-induced cell death in substantia nigra-derived cell line. Toxicol Sci 121:376\u2013388","journal-title":"Toxicol Sci"},{"issue":"Suppl 1","key":"9747_CR36","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.parkreldis.2015.08.015","volume":"22","author":"S Petrucci","year":"2016","unstructured":"Petrucci S, Ginevrino M, Valente EM (2016) Phenotypic spectrum of alpha-synuclein mutations: new insights from patients and cellular models. Parkinsonism Relat Disord 22(Suppl 1):S16\u2013S20","journal-title":"Parkinsonism Relat Disord"},{"key":"9747_CR37","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/jnc.12686","volume":"129","author":"J Segura-Aguilar","year":"2014","unstructured":"Segura-Aguilar J, Paris I, Mu\u00f1oz P, Ferrari E, Zecca L, Zucca F (2014) Protective and toxic roles of dopamine in Parkinson\u2019s disease. J Neurochem 129:898\u2013915","journal-title":"J Neurochem"},{"key":"9747_CR38","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2174\/0929867323666151223094103","volume":"23","author":"J Segura-Aguilar","year":"2016","unstructured":"Segura-Aguilar J, Mu\u00f1oz P, Paris I (2016) Aminochrome as new preclinical model to find new pharmacological treatment that stop the development of Parkinson\u2019s disease. Curr Med Chem 23:346\u2013359","journal-title":"Curr Med Chem"},{"key":"9747_CR39","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"M Spillantini","year":"1998","unstructured":"Spillantini M, Crowther R, Jakes R, Hasegawa M, Goedert M (1998) Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A 95:6469\u20136473","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"52","key":"9747_CR40","doi-asserted-by":"crossref","first-page":"43179","DOI":"10.1074\/jbc.M507624200","volume":"280","author":"TS Ulmer","year":"2005","unstructured":"Ulmer TS, Bax A (2005) Comparison of structure and dynamics of micelle-bound human alpha-synuclein and Parkinson disease variants. J Biol Chem 280(52):43179\u201343187","journal-title":"J Biol Chem"},{"key":"9747_CR41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nbd.2009.03.004","volume":"34","author":"V Van Laar","year":"2009","unstructured":"Van Laar V, Mishizen A, Cascio M, Hastings T (2009) Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells. Neurobiol Dis 34:487\u2013500","journal-title":"Neurobiol Dis"},{"key":"9747_CR42","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1021\/bi030086j","volume":"42","author":"M Volles","year":"2003","unstructured":"Volles M, And Lansbury P (2003) Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson\u2019s disease. Biochemistry 42:7871\u20137878","journal-title":"Biochemistry"},{"key":"9747_CR43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12035-012-8341-2","volume":"47","author":"M Xilouri","year":"2013","unstructured":"Xilouri M, Brekk O, Stefanis L (2013) Alpha-synuclein and protein degradation systems: a reciprocal relationship. Mol Neurobiol 47:537\u2013551","journal-title":"Mol Neurobiol"},{"key":"9747_CR44","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F","volume":"54","author":"Y Xu","year":"1998","unstructured":"Xu Y, Stokes A, Roskoski R, Vrana K (1998) Dopamine in the presence of tyrosinase covalently modifies and inactivates tyrosinase hydroxylase. J Neurosci Res 54:691\u2013697","journal-title":"J Neurosci Res"},{"key":"9747_CR45","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2353\/ajpath.2009.080928","volume":"175","author":"W Yu","year":"2009","unstructured":"Yu W, Dorado B, Figueroa H, Wang L, Planel E, Cookson M, Clark L, Duff K (2009) Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric \u03b1-synuclein. Am J Pathol 175:736\u2013747","journal-title":"Am J Pathol"},{"key":"9747_CR46","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1124\/mol.106.024703","volume":"70","author":"KS Zafar","year":"2006","unstructured":"Zafar KS, Siegel D, Ross D (2006) A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition. Mol Pharmacol 70:1079\u20131086","journal-title":"Mol Pharmacol"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-017-9747-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-017-9747-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-017-9747-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T03:24:22Z","timestamp":1504668262000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-017-9747-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,6]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["9747"],"URL":"https:\/\/doi.org\/10.1007\/s12640-017-9747-4","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,6]]}}}